Clinical Trials Browser

Phase EARLY_PHASE1 × Cisplatin × Gastrointestinal × Clear all

Ototoxicity, Neoplasms, Germ Cell and Embryonal, Hepatoblastoma

NCT04213794 2025-02-20

TOASTIT

GastrointestinalGynecologicOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Colonic Neoplasms, Fallopian Tube Neoplasms, Liposarcoma, Ovarian Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Rhabdomyosarcoma, Sarcoma, Stomach Neoplasms, Desmoplastic Small Round Cell Tumor

NCT06690476 2024-11-15

Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma

Phase EARLY_PHASE1 Recruiting

74 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02550327 2021-06-22

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer

Phase EARLY_PHASE1 Completed

20 enrolled

Gastrointestinal

Pancreatic Adenocarcinoma

Clinical Trials

Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy

TOASTIT

Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of IPM514 in Patients with Esophageal Squamous Cell Carcinoma

Gemcitabine, Nab-Paclitaxel, Cisplatin and Anakinra Treatment on Patients With Pancreatic Cancer